Introduction: Increased healthcare utilisation in CF patients may be associated with MRSA acquisition. This study aimed to determine (i) the similarity of MRSA isolated from CF and non-CF patients in two centres [University of Washington (UW) and Royal Belfast Hospital for Sick Children (RBHSC)], and (ii) the evidence for shared patient clones, which may indicate transmission. Methods: MRSA isolates from patients in Seattle (n = 71 from 23 paediatric CF patients; n = 20 from non-CF MRSA colonized patients; n = 10 from non-CF respiratory patients; n = 22 from non-CF non-respiratory patients) and Belfast (n = 24 from CF paediatric isolates; n = 11 non-CF paediatric patients; n = 17 non-CF colonized patients) were compared using Pulsed Field Gel Electrophoresis (PFGE). Isolates were considered similar if they possessed >60% homology. Results: Both UW and RBHSC CF and non-CF MRSA isolates formed closely related PFGE groups, regardless of disease background (RBHSC: >70%, UW: >67%). In general, isolates were not regarded as being similar in between-centre comparisons (44%). Sequential isolates from individual UW patients shared a high degree of homology (>90%). Conclusions: CF-MRSA strains were similar to endemic strains in circulation among non-CF patients in the local healthcare setting. The clonal nature of infection observed both within-centre, and in UW sequential paediatric isolates, suggests repeated acquisition from an MRSA reservoir, or more likely, persistence within the patient. This study supports a role for rigorous infection control and development of appropriate eradication strategies to prevent transmission and subsequent colonization/infection of CF patients.
Burkholderia cepacia is a significant cause of morbidity in CF. The prevalence has increased from 2% in 2003 to 20% in 2005 in our center. The outbreak was due to Burkholderia contaminans (Bc), a recently described species, but there are no clinical data published about the impact in CF. Objective: To assess the impact of Bc on pulmonary and nutritional status. Methods: Observational retrospective study. CF patients with Bc (2 positive sputum culture in BCSA medium over 6 months), confirmed by recA gen and as contaminans species by PCR. We assess data for lung function: % of predicted FEV 1 and FVC and nutritional status: z-Body Mass Index (zBMI), weight for age (zW/A) and height for age (zH/A), evaluated 12 months before the first isolation (PRE) and 12 months after the isolation (POST). Statistical analysis: paired t test. Results: 49 patients included. Median age at isolation: 7.9 years; 42% coinfected with Pseudomonas aeruginosa at isolation (Bc+Ps). Mean PRE FEV 1 was 78% and POST 
